Unlocking the Impact of Renal Function on Acute Coronary Syndrome: Insights from A Cohort Of 318 Cases
Downloads
Introduction: Chronic kidney disease (CKD) represents a distinct risk factor by itself for the development of coronary artery disease (CAD). Notably, CAD stands as the primary driver of both sickness and death among individuals diagnosed with CKD. Furthermore, individuals with CKD tend to experience worse outcomes when it comes to CAD. In addition to conventional risk factors, numerous factors associated with uremia, including inflammation, oxidative stress, endothelial dysfunction, coronary artery calcification, elevated homocysteine levels, and the use of immunosuppressants, have been linked to an increased risk of accelerated atherosclerosis.
Objective and method: In this study, we aim to assess the differential effect of renal impairment across the spectrum of patients with acute coronary syndrom. We conducted this study in the intensive care unit of cardiology in the Military Teaching Hospital of Rabat.
Results: A total of 318 patients were included in the study. The average age was 63.8 +/- 9.41 years and 77% (244/318) were male. Normal kidney function was reported in 72.8% (220/318) of patients.
Of the 318 included patients, 121(38.3%) were presented with STEMI, 154 (48.7%) with NSTEMI, and 41 (13%) with unstable angina. The difference of age was significant with a p-value of <.001 with a mean of age of 61.8 in patients with normal renal function vs 68.1 in impaired renal function patients.
Patients with impaired GFR had more history of previous PCI (21) compared to those with normal GFR (23) with a p value of 0.001. Hb was lower (12.5vs 13.9 p<0.01) and Grace score was higher (45 vs44 p<.001) in patients with impaired GFR vs patients with normal GFR.
Percentage of cardiogenic shock and death was respectively higher in renal impairment (12(60%) vs 8 (40%) with p of 0.004); (10(62.5%) vs 6(37.5%) with p 0.005.
Conclusion:The magnitude of renal impairment is significant in our study in the most deadly complication: cardiogenic shock and death; which confirms that outcomes of coronary artery disease especially in acute coronary syndrome are significantly poorer in patient with kidney disease.
Categories: Cardiology
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C yuan: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004, 351:1296-305. 10.1056/NEJMoa041031
Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney international. 2003, 63:793-808. 10.1046/j.1523-1755.2003.00803.x
Cheung AK, Sarnak MJ, Yan G, et al.: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney international. 2000, 58:353-62. 10.1046/j.1523-1755.2000.00173.x
Moe SM, Chen NX: Mechanisms of vascular calcification in chronic kidney disease . Journal of the American Society of Nephrology. 2008, 19:213-6. 10.1681/ASN.2007080854
Moisi MI, Rus M, Bungau S, et al.: Acute coronary syndromes in chronic kidney disease: clinical and therapeutic characteristics. Medicina. 2020, 56:118. 10.3390/medicina56030118
Wetmore JB, Broce M, Malas A, Almehmi A: Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease. Nephron Clinical Practice. 2012, 122:9-16. 10.1159/000347143
Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM: Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective. American Journal of Kidney Diseases. 2006, 47:378-84. 10.1053/j.ajkd.2005.11.017
Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA: Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. Journal of the American Society of Nephrology. 2003, 14:3233-8. 10.1097/01.asn.0000095642.25603.7a
Winkelmayer WC, Charytan DM, Levin R, Avorn J: Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. American journal of kidney diseases. 2006, 47:301-8. 10.1053/j.ajkd.2005.10.009
Drury PL, Ting R, Zannino D, et al.: Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2011, 54:32-43. 10.1007/s00125-010-1854-1
Susantitaphong P, Riella C, Jaber BL: Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis. Nephrology Dialysis Transplantation. 2013, 28:438-46. 10.1093/ndt/gfs514
Wright RS, Reeder GS, Herzog CA, et al.: Acute myocardial infarction and renal dysfunction: a high-risk combination. Annals of internal medicine. 2002, 137:563-70. 10.7326/0003-4819-137-7-200210010-00007
Beattie JN, Soman SS, Sandberg KR, et al.: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. American Journal of Kidney Diseases. 2001, 37:1191-200. 10.1053/ajkd.2001.24522
Gibson CM, Pinto DS, Murphy SA, et al.: Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. Journal of the American College of Cardiology. 2003, 42:1535-43. 10.1016/j.jacc.2003.06.001
Hachinohe D, Jeong MH, Saito S, et al.: Management of Non-ST-Segment Elevation Acute Myocardial Infarction in Patients With Chronic Kidney Disease (from the Korea Acute Myocardial Infarction Registry). The. American journal of cardiology. 2011, 108:206-13. 10.1016/j.amjcard.2011.03.025
Ix JH, Mercado N, Shlipak MG, et al.: Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). American heart journal. 2005, 149:512-9. 10.1016/j.ahj.2004.10.010
Copyright (c) 2024 Hanaa El Ghiati, Hind Ouaouicha, Hamza Chraibi, , Zineb Fassi Fehri, Najat MOUINE, ZOUHAIR LAKHAL, Aatif Benyass
This work is licensed under a Creative Commons Attribution 4.0 International License.
All Content should be original and unpublished.